Improving Inhaled Corticosteroid Prescribing Practices for Children Admitted With an Asthma Exacerbation
Pediatric Pulmonology · 2026-11 · 61 (11)
DOI: 10.1002/ppul.71924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 16.11.2026. Verfasst von Zenna Solomon und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York, USA. Hauptthemen laut MEDLINE: Asthma, Adrenal Cortex Hormones, Practice Patterns, Physicians', Anti-Asthmatic Agents. Die Arbeit nennt 19 Literaturangaben. Gefördert von: National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), Weill Cornell Medicine Department of Pediatrics Quality and Patient Safety Project Support Award.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Asthma management guidelines recommend inhaled corticosteroids (ICS), including as‐needed use, to treat airway inflammation, reduce bronchial hyperresponsiveness, and thereby lower the risk of severe exacerbations. Our objective was to achieve a 90% inpatient ICS initiation rate for children hospitalized with an acute asthma exacerbation over a 12‐month period. We focused our initiative on hospitalized children to target those at greatest risk of asthma‐related morbidity.
Methods
The Model for Improvement was used to define study aims/measures and create a key driver diagram to guide intervention design. Interventions focused on enhancing ICS access, standardizing workflow, healthcare provider asthma education, and integrating clinical decision support into the electronic health record. We performed serial planned experimentation to test interventions using Plan‐Do‐Study‐Act (PDSA) cycles. Shewhart P‐charts and established rules for detecting special cause variation were used to analyze data. Our outcome measure was ICS initiation rate during inpatient hospitalization among children discharged on ICS therapy. Process measures were the percentage of children for whom asthma severity was assessed on admission, and the percentage of children continued on home ICS therapy during admission. The balancing measure was length of stay.
Results
The percentage of children initiated on ICS therapy during admission increased from 16% to 80% over a 12‐month period with further improvement reaching 94% 1‐year post‐intervention. There was no change in length of stay.
Conclusion
The availability of a pediatric‐appropriate ICS on hospital medication formulary and the initiation of an asthma clinical management pathway were the most impactful interventions to improve ICS prescription for children admitted with an asthma exacerbation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, New York, USA.
- Department of Pediatrics, New York-Presbyterian Hospital Queens, Flushing, New York, USA.
ORCID-Profile: Zenna Solomon, Kalliope Tsirilakis
Förderung
- National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
- Weill Cornell Medicine Department of Pediatrics Quality and Patient Safety Project Support Award
Zitieren
APA
Solomon, Z., & Tsirilakis, K. (2026). Improving Inhaled Corticosteroid Prescribing Practices for Children Admitted With an Asthma Exacerbation. Pediatric Pulmonology, 61(11). https://doi.org/10.1002/ppul.71924
Vancouver
Solomon Z, Tsirilakis K. Improving Inhaled Corticosteroid Prescribing Practices for Children Admitted With an Asthma Exacerbation. Pediatric Pulmonology. 2026;61(11). doi:10.1002/ppul.71924
BibTeX
@article{Solomon2026,
author = {Solomon, Zenna and Tsirilakis, Kalliope},
title = {Improving Inhaled Corticosteroid Prescribing Practices for Children Admitted With an Asthma Exacerbation},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {11},
doi = {10.1002/ppul.71924}
}
EUVIMED